Lichen Planus Market: Will 2026 Be the Year Targeted Biologics Finally Conquer This Chronic Condition?
As of January 21, 2026, the global lichen planus market is identifying as a rapidly evolving segment of the autoimmune dermatology sector, with its 2026 valuation reaching approximately $720 million. The 2026 landscape is defined by a significant transition from broad-spectrum immunosuppressants to "Precision Biologics" that target specific inflammatory pathways like IL-17 and JAK/STAT...
0 Комментарии 0 Поделились 471 Просмотры 0 предпросмотр